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Abstract:  
 
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a comprehensive and 
integrated approach to the delivery of early intervention and treatment services through universal 
screening for persons with substance use disorders and those at risk. This paper describes 
research on the components of SBIRT conducted during the past 25 years, including the 
development of screening tests, clinical trials of brief interventions and implementation research. 
Beginning in the 1980s, concerted efforts were made in the US and at the World Health 
Organization to provide an evidence base for alcohol screening and brief intervention in primary 
health care settings. With the development of reliable and accurate screening tests for alcohol, 
more than a hundred clinical trials were conducted to evaluate the efficacy and cost effectiveness 
of alcohol screening and brief intervention in primary care, emergency departments and trauma 
centers. With the accumulation of positive evidence, implementation research on alcohol SBI 
was begun in the 1990s, followed by trials of similar methods for other substances (e.g., illicit 
drugs, tobacco, prescription drugs) and by national demonstration programs in the US and other 
countries. The results of these efforts demonstrate the cumulative benefit of translational 
research on health care delivery systems and substance abuse policy. That SBIRT yields short-
term improvements in individuals' health is irrefutable; long-term effects on population health 
have not yet been demonstrated, but simulation models suggest that the benefits could be 
substantial. 
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Article: 
 
INTRODUCTION 
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a comprehensive, integrated, 
public health approach to the delivery of early intervention and treatment services for persons 
with substance use disorders, as well as those who are at risk of developing them. SBIRT is 
based on public health principles and procedures, and is designed to reduce the bur- den of 
injury, disease and disability associated with the misuse of psychoactive substances, particularly 
alcohol, illicit drugs, tobacco products, and prescription medications with high abuse potential. 
The aims of this review are to summarize the research base and state of knowledge on SBIRT. 
For the purposes of this review, the following are considered core components of SBIRT: 
 
• Screening: SBIRT begins with the introduction of systematic screening into the normal 
routine at medical facilities and other community settings where persons with substance use 
disorders are likely to be found. Screening is by definition a preliminary procedure to evaluate 
the likelihood that an individual has a substance use disorder or is at risk of negative 
consequences from use of alcohol or other drugs. Whereas screening tests were initially 
developed to identify active cases of alcohol and drug dependence, in recent years the aim has 
been expanded to cover the full spectrum ranging from risky sub- stance use to alcohol or drug 
dependence. Because the population of persons with risk factors is much larger than the 
population of dependence cases (1), SBIRT programs focusing on early intervention have 
generally adopted a broad definition of screening. 
• Brief intervention: The term brief intervention refers to any time-limited effort (e.g., 1-2 
conversations or meetings) to provide information or advice, increase motivation to avoid 
substance use, or to teach behavior change skills that will re- duce substance use as well as the 
chances of negative consequences. Brief interventions are typically delivered to those individuals 
at low to moderate risk. Among the most cost-effective and time efficient interventions are brief 
motivational conversations between a health care professional and a substance user. 
• Brief treatment: Brief treatment refers to the delivery of time-limited, structured (or 
specific) therapy for a substance use disorder by a trained clinician and is typically delivered to 
those at higher risk or in the early stages of dependence. It generally involves 2-6 sessions of 
cognitive-behavioral or motivational enhancement therapy with clients who are seeking help. 
Brief treatment may also include the on- going management of substance use dis- orders in 
primary care settings, especially with the use of new pharmaceutical agents. 
• Referral to treatment: Screening often identifies those who already have a substance-
related health condition or a suspected substance use disorder that warrants a formal diagnosis 
and possible referral to treatment. The referral process facilitates access to care (including brief 
treatment) for those individuals who have more serious signs of substance dependence and 
require a level of care outside the scope of brief services. 
• Integration and coordination activities: In many communities screening and brief 
intervention services are nonexistent, diagnostic and referral services are fragmented and 
inconsistent, and specialized treatment services operate independently of the larger health care 
system. A key aspect of SBIRT is the integration and coordination of these four components into 
a system of services linking the specialized treatment programs in a community with a network 
of early intervention and referral activities that are conducted in medical and social service 
settings. 
 
 
 
 
As shown in Figure 1, SBIRT can be described as a set of inter-related services linked by 
decision rules that determine the appropriate course of action for a given patient. When risk is    
elevated but in the low range, brief intervention is the recommended course. Evidence is lacking 
regarding an exact cutoff for moderate risk, but several screening tests such as the AUDIT(2) have 
defined a mid-range of risk scores where further assessment, monitoring and brief treatment are 
warranted. Conceptually, anyone with elevated risk is eligible to begin with brief intervention even 
if the intent of the clinician is to deliver a referral to treatment or provide brief treatment. And in 
some cases, screening can lead directly to referral without feedback and advice. For those at 
low/moderate risk, the initial clinical procedure is brief intervention. For those at moderate or high 
risk, or with dependence, the goal would be a brief intervention that encourages entry into brief 
 
treatment or specialty treatment, respectively. Clearly many people at higher risk identified 
by screening will not receive specialty treatment. Follow-up ovals include arrows pointing back to 
the risk ovals in order to stress the need for continued monitoring and referral to further 
treatment if necessary. 
 
The model for SBIRT is based in part on the Institute of Medicine (3) report that recommends 
the development of integrated service systems linking community-based screening and brief 
intervention with assessment and referral activities. One important function of SBIRT is to fill 
the gap between primary prevention efforts and more intensive treatment for persons with 
serious substance use disorders. From a public health perspective, the goal of SBIRT is to improve 
the health of a community by reducing the prevalence of adverse consequences of substance 
misuse, including but not limited to diagnosable abuse or dependence, through the 
coordination of early intervention and referral to specialized treatment. When all components 
are functioning effectively in health care and social service agencies throughout a community, 
SBIRT programs should be capable of reaching a significant proportion of the population 
using psychoactive substances. 
 
A BRIEF HISTORY OF SBIRT 
 
Although some SBIRT components date back as far as the early 18th century (4), it was not until 
the development of effective screening tests for alcohol and drug use in the 1980s that SBIRT 
emerged as a viable public health approach to addressing substance misuse. Screening 
instruments such as the MAST, the CAGE and the DAST were first developed to identify active 
cases of alcohol and drug dependence for referral to treatment (5). In the 1980s a seminal study 
by Russell et al. (6) showed how brief physician advice was capable of motivating small but 
significant numbers of patients to stop smoking. Subsequent research in Malmo, Sweden (7) 
indicated that systematic screening combined with brief interventions delivered in primary care 
settings were capable of reaching large numbers of at-risk drinkers, many of whom reduced their 
alcohol consumption in response to the program. The public health implications of the Malmo 
study for the prevention of alcohol problems led the World Health Organization (WHO) to 
initiate a program of clinical and applied research on the development of an international 
screening test and the evaluation of brief interventions for at-risk drinkers (8). That program, 
begun in 1981, led to the development of the Alcohol Use Disorders Identification Test (9) as 
well as the first cross-national clinical trial of the effectiveness of brief interventions in health 
care settings (10). The WHO program was expanded to include a consortium of re- searchers 
investigating ways to implement screening and brief intervention technologies in primary care 
settings, as well as the development of national plans to integrate SBIRT activities into the health 
care systems of both developed and developing countries (8). A related program was initiated in 
1997 to develop a screening test and brief interventions for illicit drugs as well as alcohol and 
tobacco (11). These projects have been conducted during a 25-year period when there has been a 
dramatic increase in clinical and health services research on screening and brief intervention for 
alcohol and other substances. This research has been con- ducted primarily in the United States, 
Australia and European countries and has been accompanied by evaluations of training packages, 
implementation models, program costs and systems changes necessary to facilitate the adoption 
of SBIRT programs (2). 
 
Perhaps the most significant development in this evidence-based movement to test and 
disseminate new screening and intervention technologies in the US is the Substance Abuse 
Mental Health Services Administration’s SBIRT initiative, which consists of a variety of 
demonstration programs operating in 11 states. Other large scale programs have been 
implemented in Brazil, South Africa and the European Union. In the remainder of this review, 
we will critically evaluate the literature supporting the various components of SBIRT, 
summarizing this evidence in terms of its practical applications for program planners, 
administrators, and policymakers. 
 
SCREENING 
 
An important prerequisite for the SBIRT approach is the accurate identification of people at risk 
as well as active cases of substance abuse and dependence. Screening for alcohol, tobacco and 
other drugs has been gaining popularity in health care settings because of new technologies, 
expert committee recommendations and encouraging research findings about the effectiveness of 
early intervention (5,12,13). Table 1 provides a compendium of 25 self-report screening tests for 
alcohol and other sub- stance use, abuse and dependence. The tests were identified in an 
extensive review of the literature published in peer reviewed journals covered in Index Medicus. 
For each screening test, the compendium lists the item content, target population, administration 
mode, number of items, scoring time, and the time frame of measurement.  In this section, we 
update an evaluation of screening tests initially conducted by Babor and Kadden (5). Screening 
tests for alcohol and drugs are reviewed separately, and in both types of substances we further 
distinguish between self-report screening tests and biological tests that are conducted on samples 
of body fluids. 
 
Alcohol screening tests: One of the first alcohol screening procedures, the Michigan Alco- 
holism Screening Test (MAST, 14), consists of 24 yes-no questions that list signs and symptoms 
of chronic alcoholism. The MAST has been criticized because of its length, its potential for 
falsification, and its focus on finding cases of alcohol dependence rather than early identification 
of risk factors. The shorter 12-item MAST (15) and the four-item CAGE screening test (16) 
increase the feasibility of screening but still maintain a focus on identifying active alcoholics. An 
added disadvantage of these screening tests is their use of questions measuring “lifetime” 
symptoms (“have you ever . . .”), which can produce false positives when the alcohol problems 
occurred in the past but have since remitted. A disguised screening test based on the patient’s 
history of traumatic injury (17) was developed to deal with the falsification problem, but this was 
done at the expense of sensitivity and specificity. 
 
A number of alcohol screening tests have been developed for special populations, including 
women (18,19) and the elderly (20). The World Health Organization developed the Alcohol Use 
Disorders Identification Test (AUDIT) (9,2) in order to maximize cultural and linguistic 
generalizability of screening results. The AUDIT focuses on both hazardous drinking as well as 
alcohol use disorders. The AUDIT has been well validated across different cultural groups in a 
variety of countries, and several shorter adaptations have been developed, including the AUDIT-
PC, the AUDIT- FAST, and the AUDIT-C, all of which focus mainly on the quantity, frequency 
and pattern of drinking (21,22). Finally, several single item screening tests have been developed 
and validated. Williams and Vinson (23) found that a single question about the last episode of 
heavy drinking has good sensitivity and specificity in detecting hazardous drinking and alcohol 
use disorders. O’Brien et al. (24) found that by asking “How many days do you get drunk?” in a 
typical week, they could identify college students who are at higher risk of alcohol-related injury. 
To the extent that very short screening tests may motivate clinicians to screen more often, these 
tests may have value (see, for example, 25). Nevertheless, the value of longer tests is that the 
patient’s responses to questions about drinking and alcohol problems can be the immediate point 
of departure for a brief intervention, which typically begin with a discussion of specific 
screening results. 
 
Although not recommended for routine screening, several biological markers have been useful 
adjuncts to alcohol screening in emergency medicine and criminal justice settings, such as the 
breath alcohol concentration (BAC), gamma-glutamyltransferase (GGT, a liver enzyme), and 
carbohydrate-deficient transferrin (CDT). BAC has a short half-life and does not provide 
information about risk behavior other than to estimate the extent of recent drinking. GGT and 
CDT have not been found to be sensitive or specific enough to detect heavy episodic drinking 
(26). 
 
Other psychoactive substances: Given the different needs and substance use patterns of adults 
and adolescents, self-report drug screening tests have generally been designed and validated for 
one or the other of these populations. Two types of self-report tests have been developed for 
adults. The first, exemplified by the Drug Abuse Screening Test (DAST; 27), consists of direct 
obvious or face valid questions about drug use and related problems that yields a quantitative 
score reflecting the severity of drug abuse. A later version of the DAST reduced the number of 
items from 28 to 10 without compromising reliability (28). In contrast to screening tests that ask 
directly about substance use, several tests have been developed to measure risk factors that are 
associated with actual or potential substance use disorders. However, tests of this type tend be 
quite long. For example, some of these tests are embedded in the Minnesota Multiphasic 
Personality Inventory, which contains over 500 items, and thus may not be appropriate to use in 
health care settings where there is limited time to administer and score the screening test (29). 
 
 
 
 
 
Recognizing the need for a comprehensive screening and referral test for adolescents, the 
National Institute on Drug Abuse (NIDA) developed the Problem-Oriented Screening Instrument 
for Teenagers (POSIT) (30). The POSIT consists of 139 items that generate scores indicating 
problems in ten functional areas that are related directly or indirectly to substance use disorders: 
Substance Use/Abuse, Mental Health Status, Physical Health Status, Aggressive 
Behavior/Delinquency, Social Skills, Family Relations, Educational Status, Vocational Status, 
Peer Relations and Leisure and Recreation. The test has demonstrated good reliability and 
validity in adolescents referred to an assessment service for evaluation of substance use problems 
(31), but is too long to serve as a brief screening test. One option is to use only the Substance 
Use/Abuse part of the test, which would make it more efficient for screening in general health 
care settings. 
 
In addition to the multidimensional screening approach used in the POSIT, several shorter 
instruments have been developed to screen specifically for substance use among adolescents. 
The Personal Experience Screening Questionnaire (PESQ) (32) focuses primarily on drug use 
and related problems, but also collects information on other areas of concern, such as 
psychopathology. Reliability and validity of this 38-item test have been demonstrated in the 
detection of individuals with different histories of substance use (33). Another adolescent 
screening test that has been used at adolescent treatment programs is the Substance Abuse Subtle 
Screening Inventory (SASSI, 34), a 78-item self-report instrument that classifies adolescents as 
chemically dependent. Although the SASSI was designed to prevent deliberate falsification by 
using indirect questions, it has not been found to be very accurate (35,36). Other screening tests 
have been designed for more specific populations, such as the 42-item Drug and Alcohol 
Problem (DAP) Quick Screen, which was developed for use by pediatricians (37). Validity data 
have been reported for the 30-item revision of this test (38). Finally, the CRAFFT (Car, Relax, 
Alone, Friends, Forget, Trouble) is brief (6 items) and has been validated with adolescents in 
primary care settings (39). Because of its brevity, it is more likely to be used than the longer 
instruments described above. 
 
Combined screening tests: Despite advances in the development of self-report screening tests for 
specific types of psychoactive substances, there has been considerably less attention to 
instruments that screen for multiple substances. To address this deficiency, the Alcohol, 
Smoking and Substance Involvement Screening Test (ASSIST; 11) was developed to screen for 
at-risk use of psychoactive substances as well as related problems. The test uses a common 
format to screen for 11 psychoactive substances as well as injection drug use. The scoring 
procedure estimates the relative importance of these different risk behaviors for the purpose of 
prioritizing counseling interventions. Although the ASSIST is not able to identify people who 
exceed risky drinking limits based on quantities of alcohol consumed, these questions can easily 
be added to obtain country-specific alcohol risk levels. 
 
A major challenge to combined screening for specific substances is provider burden, which 
refers to the skills and time demanded of the screening agent. A relatively simple procedure that 
addresses this problem is the CAGE test adapted to include drugs (CAGE-AID). The CAGE-
AID was found to be more sensitive but less specific than the CAGE (40). This easy-to-use four-
item test nevertheless re- quires further questioning if the patient scores positive. Thus, 
efficiency comes at the price of specificity, and screening questions using a lifetime (ever) 
approach can result in high numbers of false positives. 
 
Biological Screening Methods for Drugs: A variety of biological procedures have been 
developed to detect recent drug use through urinalysis, hair testing, and saliva tests. These 
methods are not capable of detecting sub- stance-related problems or even substance use beyond 
a narrow time window (41). Urine screening tends to be the preferred method because it is less 
invasive than blood testing and the drugs or their metabolites are present in relatively high 
concentrations in urine. A recent innovation that facilitates biological screening is the 
commercial availability of self-contained urine testing kits. These tests are easy to use and 
provide rapid access to test results, but they can only indicate drug use over the previous few 
days. Other problems include a risk of false positives by passive drug exposure or ingestion of 
foodstuffs, and false negatives due to the use of adulterants. 
 
Summary: There are a number of important issues associated with screening instruments that 
should be taken into account in the design of an integrated SBIRT program intended to serve the 
needs of a defined population. First, the accuracy of most of the self-report tests has been 
evaluated under research conditions, which tend to maximize the likelihood of good 
performance. Although most screening tests have been found to be valid, performance is likely to 
diminish in routine clinical settings. A major concern is the extent to which the results of a self-
report test can be deliberately faked or distorted in an attempt by the patient to preserve a 
respectable self-image in the health care or social service setting. Although self-report measures 
of substance use tend to be valid and reliable in the aggregate under most circumstances, 
accuracy in clinical settings depends on the degree of perceived threat in the data gathering 
situation, the cognitive processes (such as memory) that are required to produce answers to the 
questions, and the motivation and other personal characteristics of the respondent (42). A second 
consideration is cost and efficiency. Self-report tests are free or inexpensive, and they can be 
administered and scored quickly. Nevertheless, medical staff sometimes view even a small 
addition to their routine as an unnecessary burden. Although some screening tests are relatively 
brief (e.g., CAGE and AUDIT-C) and can be administered in one or two minutes, others require 
more time and ad- ministration skills. Biological tests can be costly to use on a routine basis and 
require even more time to administer and score. Nevertheless, they are often seen as being more 
consistent with routine medical practice, and this may affect their acceptability to both patients 
and staff. A third issue is cultural sensitivity. Although research has not been extensive, there is 
no evidence to suggest that the reliability or validity of self-report tests varies across different 
ethnic groups (9,11). A final issue is the target group of the screening program. Many of the 
adult screening tests described in Table 1 have been designed for finding active cases of alcohol 
or drug dependence, not to identify risk factors for drug or alcohol abuse. These tests (e.g., the 
DAST) typically avoid direct questions about use of specific drugs, focusing instead on the 
problems associated with any substance use in the past. Subtle or disguised screening tests (e.g., 
the SASSI) do not appear to be sufficiently sensitive or specific to identify active cases, but may 
be useful in screening for risk factors. Comprehensive screening tests like the POSIT and 
ASSIST are capable of identifying both “caseness” and risk factors, but they take more time to 
administer and score. Even single item or very brief screening tests like the AUDIT-C require 
further questioning once the patient screens positive, so screening tests with skip-out instructions 
like the AUDIT and ASSIST may save considerable time because most patients need not be 
screened further after negative responses to the first few questions. 
 
Brief interventions for alcohol abuse and at-risk drinking: In the first systematic review of 
research on this subject, Bien et al. (43) evaluated 32 controlled studies involving over 6000 
patients studied prior to 1992. Brief interventions with problem drinkers were often found to be 
as effective as more extensive treatments. It was concluded that the course of harmful alcohol 
use can be effectively altered by relatively brief contacts in contexts such as primary health care 
settings and employee assistance programs. Kahan et al. (44) reviewed 11 trials of physician-
based brief intervention in medical settings and concluded that brief alcohol interventions are 
effective, and their public health impact is potentially enormous. Twelve randomized controlled 
trials were reviewed by Wilk et al. (45), who concluded that brief intervention is a low-cost, 
effective preventive mea- sure for heavy drinkers in outpatient settings. Additional support for 
these conclusions, based on new analyses of many of the same studies summarized in previous 
reviews, has been reported by Ballesteros et al. (46). Moyer et al. (47) reviewed studies 
comparing brief intervention both to untreated control groups and to more extended treatments. 
They found “further positive evidence” for the effectiveness of brief interventions, especially 
among patients with less severe problems. In an extensive re- view of the literature for the U.S. 
Preventive Services Task Force, Whitlock et al. (13) concluded that behavioral counseling 
interventions for alcohol misuse among nondependent primary care patients identified by 
screening are feasible and potentially effective components of an overall public health approach 
to reducing alcohol misuse. 
 
Most of the studies cited in these reviews were conducted in primary care settings, where the 
prevalence of alcohol abuse and dependence tends to be lower than what is found in emergency 
and trauma centers. Emergency departments and trauma centers have been identified as high-
yield settings for alcohol screening (12,48,49). A large randomized trial of brief interventions in 
a trauma center (50) found that a brief motivational intervention was associated with decreased 
alcohol consumption and a reduced risk of trauma recidivism. 
 
In the course of investigating the efficacy of brief interventions with at-risk drinkers, research 
has also evaluated the extent to which behavior change is related to individual differences among 
drinkers, the professional training, ethnicity and gender of the intervention provider, and the 
nature of the intervention itself (13). In general, behavior change is not de- pendent on provider 
training or characteristics, but the dependence severity of the drinker does seem to be an 
important correlate of low response to brief intervention. Regarding the nature of the 
intervention, skills training, simple advice, and motivational approaches seem to be equally 
effective. In addition, the interventions seem to be equally effective with adolescents, adults, 
older adults, and pregnant women. 
 
Despite the general preponderance of positive findings, some studies have shown no differences 
between intervention and control groups, and many studies report significant reductions in 
control group drinking that are comparable to those of the intervention group (51). One 
explanation for this phenomenon is that the screening procedure itself has a motivational effect, 
although one study found no evidence that assessment alone was responsible for changes in the 
control group (51). The other explanation is “regression to the mean,” which describes a 
statistical tendency for extreme values such as heavy drinking to return to the group average over 
time. 
 
Brief intervention for drug use and abuse: In contrast to the alcohol literature, there have been 
few studies of brief interventions for drug abuse. Bernstein et al. (52) found that brief 
intervention in a clinical setting can reduce cocaine and heroin use. Brief intervention appeared 
to facilitate abstinence at 6 months, even in the absence of meaningful contact with the treatment 
system. Baker et al. (53) found that both the provision of a self-help booklet and a single session 
of motivational interviewing were associated with reduced amphetamine consumption among 
regular users. Two studies (54,55) have found that general practitioners can reduce excessive 
benzodiazepine use in their patients using brief interventions such as letters or consultations. 
Despite these promising findings from controlled studies, and similar positive results from 
research described below under Brief Treatment, several investigators have reported negative 
findings from brief interventions with drug users. Marsden et al. (56) evaluated the effect of a 
stimulant-focused brief motivational interview (relative to the provision of health risk 
information about stimulants) among adolescent and young adult stimulant users. No significant 
differences between groups were found for ecstasy, powder cocaine, crack or alcohol. Other 
research (53) with psychiatric inpatients showed similar lack of effectiveness. 
 
Summary: Research on brief interventions for alcohol and other substance users has accumulated 
rapidly during the past two decades. Not only are the procedures generally effective with a 
variety of population groups, they can be delivered with equal effect by a variety of health care 
providers. Less evidence is available regarding the brief interventions for drug users, but several 
studies show positive effects. An important question that requires further research is the extent to 
which brief interventions can be made more effective when combined with stepped care 
strategies that increase the intensity of the intervention for patients who do not respond initially. 
Among the options are brief treatment and referral to specialized programs serving persons with 
alcohol or drug dependence. 
 
BRIEF TREATMENT 
 
Brief treatment (BT) refers to the provision of as few as two sessions of therapy by a trained 
counselor, social worker, psychologist or psychiatrist. While brief interventions focus on 
motivating clients to change their substance use, brief treatment helps clients develop the skills 
and resources to change. BTs are often based on motivational approaches (e.g., Motivational 
Enhancement Therapy) or behavioral approaches (e.g., Cognitive-Behavioral Therapy) or a 
combination of the two. BT typically includes a standardized assessment procedure, goal-setting, 
and rapid implementation of change strategies. BT should be characterized as a self-contained 
modality, rather than fewer sessions of longer term or traditional therapy, or as more sessions of 
BI. The goals of BT differ from those of both longer term, traditional therapy and of BI. BT 
tends to focus on the present situation and emphasizes the use of effective therapeutic tools to 
make specific behavioral changes in a shorter period of time. 
 
Studies have compared BT to more intensive, traditional treatment approaches and to BI 
approaches. Many have incorporated wait- listed control groups in the experimental design. 
Stephens, Roffman and Curtin (57) compared a brief, two-session individual treatment with 14 
sessions of cognitive behavioral skills training. Both treatments produced substantial reductions 
in marijuana use relative to the delayed treatment control condition with treatment gains 
maintained at 16-month follow-up. The Marijuana Treatment Project (MTP) com- pared two 
treatment therapies with a delayed treatment control condition (58). One of the therapies 
consisted of nine individual counseling sessions delivered over a 12-week period. The other 
consisted of two motivational enhancement therapy sessions delivered over a one-month period. 
The nine-session intervention produced significantly greater reductions in marijuana use and 
associated consequences than the two-session intervention, and at each follow-up point over a 
12-month period both treatments produced outcomes superior to the four-month delayed 
treatment control condition. The results indicate that even a brief two-session treatment is 
associated with substantial reductions in marijuana use and related problems in chronic 
marijuana users. 
 
Several studies have demonstrated promising evidence that BT is often as effective as longer 
term, traditional therapies for substance use disorders (59-61). Moyer et al. (47) found positive 
evidence for the effectiveness of brief therapies, especially among patients with less severe 
problems. For clients with greater problem severity, Berglund et al. (62) noted that better results 
were observed with more treatment. Although studies show that patients who receive more 
outpatient mental health care tend to have better short-term substance use outcomes (63-65), 
there is growing evidence that duration and continuity of care is more important than the amount 
or intensity of care (66-69). The finding that duration of treatment (rather than amount of 
treatment) for alcohol and drug use disorders is more closely related to outcome suggests that 
more resources should be devoted to interventions such as brief treatments that are linked to 
other continuity of care options (70). 
 
Summary: BT models are consistent with a public health approach in which large numbers of 
individuals at risk of developing serious alcohol or other drug problems may be identified 
through primary care screening or through court-mandated treatment (e.g., stemming from DUI 
arrests). The BT target population has traditionally been those individuals with less severe 
substance use disorders. However, there is a growing body of evidence to suggest that brief 
treatments are effective with a wide range of clients, including persons with mild to moderate 
alcohol dependence and regular marijuana users. BT may also be appropriate for some patients 
when previous attempts using traditional treatment approaches have failed, when there are 
insufficient resources (e.g., client time or insurance coverage) available for longer-term therapy, 
or when there are long waiting lists for specialized treatment. There is no question that BT is 
more effective than being on a waiting list and could benefit large numbers of clients who are 
seeking and waiting for longer term care (71). 
 
MEDICATION-ASSISTED TREATMENT IN HEALTHCARE SETTINGS 
 
Recent advances in pharmacological treatment for alcohol and opioid dependence provide 
significant opportunities to integrate the management of substance use disorders into primary 
health care. After screening and brief intervention, pharmacotherapy can be initiated in health 
care settings to assist patients undergoing BT or to facilitate the transition to traditional substance 
abuse treatment. 
 
Medications for alcohol disorders: Four FDA-approved medications are available that 
physicians can prescribe to dampen craving, reduce heavy drinking, and/or promote abstinence. 
These are: naltrexone, a μ (mu)-opiate receptor antagonist; depot naltrexone, an extended-release 
form of naltrexone that is injected monthly; acamprosate calcium delayed-release tablets; and 
disulfiram (under supervised administration). These medications can be helpful to patients who 
are struggling to maintain sobriety and for preventing relapse after referral to treatment. 
Of particular interest to SBIRT, one recent study looked at whether general internists and 
primary care physicians could treat alcohol-dependent patients as effectively as addiction 
specialists, using naltrexone (72). Results indicated that primary care counseling with naltrexone 
pharmacotherapy is a promising approach that can be effective in selected patients. In addition, 
the long acting, injectable form of naltrexone that is now available may enhance its use in 
primary care settings (73). 
 
With the newer medications now available, there is increasing interest in whether alcohol-
dependent individuals can be treated successfully with FDA-approved medications by their 
primary care physicians in routine medical practice. The comprehensive COMBINE clinical trial 
at 11 sites with nearly 1,400 patients explored a variety of treatment methods– alone and in 
combination–within the context of medical management (74). Alcohol consumption decreased 
by 80 percent over a 4-month treatment period, which suggests that medical management by 
primary physicians in routine practice can be of benefit in treating alcohol dependence (75). 
However, the medical management used in the COMBINE trial was relatively intensive (nine 
20-minute sessions), so the minimal level of contact with primary care physicians necessary to 
manage alcohol-dependent patients has not yet been determined. 
 
The COMBINE Study also found that naltrexone in combination with a brief behavioral therapy 
delivered by licensed health care professionals is more effective than more intensive behavioral 
therapy delivered by licensed behavioral health specialists (74). 
 
Medications for drug dependence: The Drug Addiction Treatment Act of 2000 established a new 
paradigm for the medication-assisted treatment of opioid dependence. Qualifying physicians in a 
medical office or other appropriate settings may now apply to the Substance Abuse and Mental 
Health Services Administration (SAMHSA) to prescribe and/or dispense opioid medications for 
treating opioid addiction. Two sublingual formulations of buprenorphine, a long-acting partial 
agonist of mu opioid receptors, have been approved by the FDA for this purpose. 
 
The decision to allow office based treatment of buprenorphine was based on a large body of 
clinical experience from other countries and the United States (76-78). A Cochrane Review 
meta-analysis of 13 randomized clinical trials concluded that buprenorphine is an effective 
intervention for use in the maintenance treatment of heroin dependence (79). 
 
REFERRAL TO ASSESSMENT AND SPECIALIZED SUBSTANCE ABUSE 
TREATMENT 
 
Research suggests that brief intervention alone may not be sufficient therapy for severely 
dependent drinkers (80). Because many brief intervention trials specifically exclude people 
dependent on alcohol or drugs, it is not known whether this population may be helped by brief 
interventions alone. Thus, for patients with severe conditions, SBIRT programs need to make 
referrals to more intensive treatment and to mutual support groups such as Alcoholics 
Anonymous (AA), Narcotics Anonymous (NA), and Cocaine Anonymous (CA). 
 
Research demonstrates that hospital patients identified as substance dependent during medical 
screening (most of whom are not seeking treatment) can be effectively referred and engaged in 
specialized treatment at rates much greater than controls (81-85). In these individual program 
studies, brief interventions have increased the percent of patients who show up for their first 
clinic appointment from 5 percent among controls to from 50 to 65 percent, with as many as 50 
percent of patients reporting that they continue to be involved in some kind of substance abuse 
treatment or 12-step meetings on follow-up (81-83). 
 
Information is limited about the prognosis for alcohol- and drug-dependent patients seen and 
referred in other medical settings, where patients are highly heterogeneous in terms of type, 
stage, and severity of substance problems, with many of these patients not motivated to start 
treatment (86). Prognosis appears to be strongly related to the patient’s motivation to enter 
treatment, as well as to change drinking or drug-using behavior (85). 
 
The literature provides little information about the specific referral processes used by various 
SBIRT programs. However, existing evidence suggests that brief motivational interventions have 
positive benefit on patients’ participation in substance abuse treatment and retention in treatment. 
For example, when one hospital replaced staff referrals with motivational interview techniques 
done by alcohol specialists, the percent of referred patients who completed treatment increased 
from 40 to 88 percent (85). In another study, 65 percent of patients who received a brief 
motivational intervention kept their initial interview at an alcohol clinic, compared to 5.4 percent 
of the control group (83). 
 
These findings indicate that SBIRT referral methods need to address the patient’s motivation to 
be treated, with the added intention of reducing the risk of dropout and assisting the patient’s 
adherence to treatment. Based on the available literature, it is not possible to say which brief 
intervention approaches, in which settings, and with which patients will be most effective for 
promoting entry and engagement into specialized alcohol or drug treatment. The research shows 
that the earlier substance-dependent patients engage in treatment or mutual-help groups, the 
better the outcomes (87,88). 
 
IMPLEMENTATION, INTEGRATION AND COORDINATION ACTIVITIES 
 
A major challenge to the public health impact of SBIRT is the difficulties involved in integrating 
its components into relevant parts of the health care system. 
 
Screening: As noted above, progress has been made in the development of a variety of effective 
screening procedures. Nevertheless, a number of practical and logistical issues need to be 
resolved before a screening program can be implemented. These issues relate not only to who 
does the screening, but when, where, how often and who pays for it. Given the simplicity of most 
self-report screening tests, they are capable of being administered in variety of different settings 
and modalities, such as interview, questionnaire, and computer. Dyches et al. (89) describe an 
interactive telephone technology for screening with primary care patients. Both patients and 
practitioners had rated the procedure positively. Under some circumstances, impersonal 
procedures, such as paper and pencil questionnaires and computer-assisted telephone interviews, 
may be more effective than face-to-face interviews with physicians. Saitz et al. (90) report 
50,000 visits a year for screening at an internet web site where positive cases received advice and 
information, suggesting that an accessible web site can attract high risk drinkers for screening 
and brief intervention. 
 
In the absence of routine screening with standardized instruments, physicians do not 
systematically apply NIAAA guidelines regarding hazardous drinking levels (91) and may be 
selective in whom they screen. One study (92) found that physicians were least likely to initiate 
discussions about drinking with patients who are white, female and widows. A Danish study of 
screening by general practitioners (93) reported that physicians did not think all patients should 
be screened. The major barriers were lack of time and financial incentives, and skepticism that 
patients wanted to be screened. 
 
Some investigators (94) have argued that primary health care is not an effective or efficient place 
to conduct alcohol screening. Others have suggested alternative sites for screening and 
professionals who can conduct it. Anderson et al. (95) identified the clergy as potential providers 
of screening and brief intervention.  Hungerford et al. (96) report that screening in an emergency 
department can produce high rates of acceptance of counseling about alcohol use. In a rural 
university emergency department (12), only 3% of the patients screened or counseled were 
uncooperative; 70% thought the emergency department was a good place to help patients with 
alcohol problems. Another potential setting for screening programs is trauma centers. Schermer 
et al. (97) found that 70% of trauma patients were successfully screened, with less than 1% 
refusing. Nevertheless, a survey (98) of 50 insurance commissioners indicated 38 states where 
there are concerns about the possibility that screening will affect insurance payments, which can 
be denied in many states if the patient has been drinking.  
 
Brief intervention: According to Roche and Freeman (99), physician-based secondary prevention 
efforts based on brief interventions for hazardous drinking have failed at the implementation 
stage. Barriers to implementation include lack of time, poor diagnostic skills, negative attitudes, 
and perceptions of role incompatibility (100). In a survey of 711 trauma surgeons (97), 83% 
agreed that the trauma center was an appropriate setting but only 25% used formal screening 
questionnaires and less than one half of problem patients are addressed in their hospital stay. 
Barriers included cost, time, confidentiality and threats to insurance coverage. To overcome 
some of these barriers, other delivery agents (e.g., nurses) have been considered. D’Onofrio and 
Degutis (101) describe the use of non-physician health promotion advocates (HPAs) to do SBI 
and referrals in the emergency department. 
 
Another way to expand the use of brief interventions is through internet applications. A review 
of the small number of web-based interventions (102) found that a demand does seem to exist for 
this kind of service and the potential impact could be considerable. As noted above, Saitz et al. 
(90) recorded 50,000 screening visits a year at an internet web site. Positive cases received 
advice and information, suggesting that an accessible web site can attract high-risk drinkers for 
brief interventions. 
 
Another barrier to brief intervention is competition for the provider’s time once a patient screens 
positive. Saitz et al. (103) showed that the very act of screening can prompt physicians to 
increase discussions and provide advice. Brady et al. (104) found that prompting of providers 
using other means doubled the rate of brief intervention. In a study by Kaner et al. (105), patient 
and practitioner characteristics predicted who got a brief intervention after screening: males, the 
unemployed, and technically trained workers were more likely to receive an intervention than 
females and employed persons. In addition, practitioners with more training and longer practice 
experience were more likely to deliver interventions. Babor et al. (106,107) compared two 
different implementation strategies for Cutting Back, a primary care alcohol screening and brief 
intervention program for hazardous and harmful drinkers. In one model, medical providers were 
responsible for delivering interventions. In another model mid-level professionals (usually 
nurses) acted as the clinic specialists to provide that service. In a sample of 10 health clinics, the 
mid-level professionals screened a higher percentage of patients than did the medical providers 
during the best month of program operation (50% vs. 44%) and overall months of operation 
(24% vs. 19%). Of those patients who screened positive, more patients screened by the mid- 
level professionals received an intervention than in the provider model (73.1% vs. 57.1%). The 
ability of clinics to conduct SBI was significantly correlated with both staffing characteristics 
and organizational factors (e.g., prior experience, organizational stability, number of clinicians 
trained and the quality of the coordinator’s work). Lack of time, staff turnover and competing 
priorities correlated negatively with SBIRT implementation. 
 
In summary, the primary obstacles to the use of SBIRT in applied settings are: (1) lack of time 
for overburdened health care workers; (2) training and motivation of professionals to administer 
screening and intervention to at-risk drinkers; and (3) organizational factors including 
administrative support and competing priorities. Successful implementation of the technology 
tends to occur at those sites where clinicians are reimbursed for their services and are well 
trained for the task. In addition, the extent to which a given delivery model is likely to work best 
within a managed care organization depends on complex provider and organizational 
characteristics. 
 
Brief treatment: Although there are insufficient data to determine which populations might 
benefit most from Brief Treatment, a growing literature suggests that BT is effective with a wide 
range of substance abusing clients. Further, the majority of clients receiving substance abuse 
treatment stay in therapy for relatively short periods of time (between 6 and 20 one-hour 
sessions). Although this statistic argues for a greater use of structured BT approaches in current 
clinical practice, DHHS (71) found that many therapists trained in traditional approaches were 
resistant to using structured BT models. A related problem is that brief treatment is typically 
developed, evaluated and delivered in an individual therapy format, whereas traditional treatment 
tends to be offered in group format because of cost considerations. 
 
The demonstration of several efficacious brief treatment interventions, especially for marijuana 
dependence, raises questions about how best to engage chronic marijuana users in treatment and 
how best to maintain improvements following treatment. Unfortunately, very little research has 
been conducted in these areas. A pilot study was conducted to evaluate a program designed to 
offer a guided self-assessment (but not treatment) to persons interested in changing their 
marijuana use. It successfully used a variety of recruitment strategies to attract participants, 
including posters, radio and newspaper ads, and outreach at various community events (108). 
The check-up program offered a useful method for reaching non-treatment-seeking heavy 
marijuana users, and at follow-up program participants reported a significant reduction in the 
frequency of marijuana use when compared to those who just got information. These results 
suggest that stand-alone programs that provide discrete treatment to regular marijuana users may 
be feasible and can reach large numbers of clients if they are properly designed and advertised. 
 
Training and technology transfer: Training in how to conduct screening and brief interventions is 
clearly a vital component in assuring effective implementation of SBIRT components. 
Introducing new screening and prevention activities into primary care practices and other settings 
presents significant challenges to professional training and continuing education. Medical 
schools and residency programs devote limited faculty resources and curriculum time to 
substance abuse (109-111) and many professionals feel inadequately trained when faced with 
patients who have substance-related problems (112,113). Barriers to adequate coverage of 
alcohol and drug-related problems in both medical schools and continuing professional education 
include traditional attitudes about the moral culpability of chronic alcoholics, confusion as to 
whether problem drinking is a medical or psychiatric concern, lack of faculty role models, lack 
of training materials, and role ambiguity regarding who is responsible for screening and 
intervention (114,115). Research on medical education has shown that training can be effective 
in improving students’ and physicians’ knowledge and skills in addressing alcohol issues (106, 
116-118), but changes in knowledge may be easier to produce than changes in attitudes and 
behavior (119). A review of the components and outcomes of medical education in substance-
related disorders concluded that the selection of a combined didactic and interactive educational 
strategy may be the most cost-effective learning strategy, but there is little empirical evidence to 
support this approach (119). 
 
Although some progress has been made in the development of SBIRT for medical practitioners, 
medical students, and health care organizations (1,120,121), a necessary step toward 
dissemination is the development of successful training packages that include program 
implementation procedures. Babor et al. (106) found that following a relatively short (3-hour) 
work- shop and subsequent supervision, physicians experienced an increased sense of confidence 
in performing screening procedures. In addition, non-physician clinicians perceived fewer 
obstacles to screening patients after receiving the training. When delivered in the context of a 
comprehensive SBIRT implementation program, training was effective in changing providers’ 
knowledge, attitudes, self-efficacy and practice of screening and brief interventions for at-risk 
drinking. The results are consistent with other studies of provider behavior (116,122,123) which 
show that health care providers trained to deliver a brief alcohol intervention will counsel their 
at-risk patients when cued to do so and when supported by a primary care office system. Adams 
et al. (123) found that a 2.5-hour training doubled the rate of alcohol interventions in high-risk 
primary care patients. Wilk and Jensen (124) used standardized patients (i.e., actors who play the 
role of symptomatic patients) to train residents to use SBI. After training more residents 
conducted screening and brief interventions. Gomel et al. compared three strategies to market 
and train primary care physicians. Telemarketing was more cost-effective than academic 
detailing and direct mail in promoting uptake of an SBI package. Roche et al. (117) compared 
two educational programs to train medical students; interactive training was no more effective 
than traditional didactic lectures in developing knowledge and skills. These studies suggest that 
SBIRT training can be effective in providing skills, increasing self-efficacy, and changing 
provider behavior. 
 
In summary, training programs have been developed and adapted to specialty settings (e.g., 
physicians in primary care clinics). Educational materials for use with problem drinkers have 
also been developed. Manuals, pamphlets, and books have been written to help train 
professionals in the process of SBI. Research on all of these training packages suggests that they 
increase knowledge about drug misuse, but they vary in their ability to change provider behavior. 
More research is needed on how increased knowledge translates into behavior changes and what 
factors help to sustain those behavior changes. 
 
ECONOMIC CONSIDERATIONS 
 
There are several important economic issues to consider in relation to implementing SBIRT. 
Providers, financial managers, and decision makers need accurate information about the costs of 
screening and brief interventions and estimates of the revenue potential. Decision makers also 
need to know the cost-effectiveness of various SBIRT models in order to choose between lower 
cost/less effective models and higher cost/more effective models. Cost benefit estimates are 
needed to assess the net costs to health plans or to society of diverting resources to SBIRT 
activities. In this section we summarize research on each of these issues. 
 
Cost: SBIRT costs will vary, depending on the perspective from which costs are calculated, e.g., 
the provider’s, the payer’s, the patient’s, or society’s perspective. For financial management 
purposes, the total costs of SBIRT services can be broken down into their components, e.g., 
screenings, information packets, counseling sessions, and case management. From the provider’s 
perspective the cost of brief interventions depends primarily on the nature and severity of the 
client’s alcohol or drug problems, the number of sessions that comprise the interventions, the 
personnel delivering brief interventions, the resources to produce and deliver interventions (and 
treatments) and the settings in which brief interventions are provided. Providers must also 
consider the onetime costs of developing and starting the service plus any ongoing continuing 
costs such as continuing education of staff. From the client’s perspective, the cost of SBIRT 
includes the amount the client pays for the intervention beyond the premiums for health 
insurance, as well as time and transportation costs to the site where interventions are furnished. 
From a payer’s perspective, the cost of brief interventions might be defined as the amount paid 
for the service minus any financial benefit that may accrue from the reduction of future costs 
resulting from the service. From society’s perspective, the cost of brief interventions is expressed 
in terms of the market value of the best alternative use to which labor, capital, and other 
resources may be put (i.e., economic or opportunity costs). 
 
Given the various perspectives that could be used, it is not surprising that published estimates of 
the costs of SBIRT vary considerably. For example, Zarkin et al. (126) estimated screening costs 
at $0.42 per patient for a 2-minute screen versus $16 per patient by Gentilello et al. (127) and 
$497 per patient by Kunz et al. (128). Given the fact that fewer than 30 percent of patients 
screened are referred for brief interventions, efforts to reduce the initial screening costs can 
significantly reduce the overall cost of providing alcohol SBI. There is also broad variability in 
the costing methodology used in the literature. For example, brief intervention costs have been 
reported at $2.59 per patient (126), $135 per brief intervention session (128), and $0.59 median 
per member per month (insurance premium cost) (129). Obviously, the underlying variability of 
the SBI programs is a primary cause for the variation in cost estimates, but the lack of a 
consistent costing methodology contributes to the variability and limits the usefulness of cross-
program comparisons. 
 
Furthermore, current SBI cost-effectiveness and cost-benefit research often presents cost results 
without a detailed description of the costing methods used. Many of these studies do not 
adequately address how and what was actually costed (e.g., 130). Authors often take national 
wage averages and estimate the amount of time for services (e.g., 127). The most thorough cost 
estimate comes from the Cutting Back study (126), which used activity-based costing to separate 
start-up costs from ongoing implementation costs, a distinction overlooked by previous studies. 
Cutting Back is the only study to compare costs across providers and is also the first to cost 
different models of implementation. However, the SBI models studied by Zarkin et al. (126) 
were implemented exclusively for the Cutting Back research project, and therefore the authors 
were forced to make judgments as to which costs would likely be retained in a non-research 
setting. 
 
Cost effectiveness analysis: Cost effectiveness analysis (CEA) enables decision makers to 
compare the economic merits of alternative types of service, such as brief interventions and 
standard care, which represents the care that clients would ordinarily receive. Kunz et al. (128) 
found cost-effectiveness ratios for brief interventions administered in a hospital emergency 
department of $258 for a one unit reduction in the follow-up AUDIT score, $219 for a decrease 
of one drink per week, and $61 for a one percentage point decline in the follow-up probability of 
heavy drinking. In a study that applied estimates from published studies to Australia, Wutzke et 
al. (130) found that brief physician advice to at-risk drinkers resulted in additional years of life 
from fewer accidents. Dividing the cost of the intervention by the number of life-years saved 
yielded a cost of approximately Aus $1,873 per life-year saved. CEA does not, however, provide 
definitive recommendations on which program should be adopted. Rather, it provides decision 
makers with evidence on the relative benefits and costs of one program compared to another. For 
this reason, CEA alone is often not enough to justify adoption of a new program. 
 
Cost benefit analysis: Unlike CEA, CBA places a dollar value on all outcomes and directly 
compares to the dollar value of a program’s outcomes to the dollar value of its costs. As a result, 
CBA often provides definitive answers on which programs should be adopted. The program with 
the largest dollar benefit after accounting for costs should unambiguously be adopted. There are 
various methods with which to compare the benefits of a program to its costs, including: net 
benefit measures in which costs are subtracted from benefits; return on investment in which the 
benefits are expressed as a percentage return to the investment represented by the program costs; 
and the benefit cost ratio in which benefits are expressed as a ratio of the costs. The choice of 
CBA measure is largely determined by the audience, with return on investment often appealing 
more to business or corporate audiences and net benefit or benefit-cost ratios appealing more to 
academic audiences. 
 
The CBA evidence on SBIRT is generally very favorable. In a randomized trial of brief 
interventions administered in physician offices, Fleming and colleagues (131) found that a group 
receiving a brief intervention not only had significant reductions in alcohol use, they also had 
fewer hospital days and fewer emergency department visits. The intervention cost 
$205 per person ($166 from the clinic perspective and $39 from the client’s perspective) and 
saved $712 in health care costs. The benefit cost ratio of 4.3 suggests a $43,000 savings in future 
health care costs for every $10,000 spent for early intervention. The benefit cost ratio increased 
to 39:1 after factoring fewer motor vehicle and legal events into the analysis. In a CBA using 
published sources, Gentilello et al. (127) estimated that the screening and brief alcohol 
interventions provided to injured patients treated in an emergency department or admitted to a 
hospital together cost $54 per patient, or $16 plus $38, respectively. The net cost savings from 
the screening and intervention was estimated at $89 per patient, or $330 for each patient 
receiving an intervention (27 percent had a positive screen). The benefit, in the form of reduced 
direct health costs, resulted in a savings of $3.81 for every $1.00 spent on screening and 
intervention, for a benefit cost ratio of 3.8:1. If interventions were routinely offered to injured 
adult patients nationwide, it was estimated that the potential net savings might approach $1.82 
billion annually. 
 
In a retrospective study of admissions to the Naval Medical Center in Portsmouth, Virginia, 
Storer (132) estimated that intervention patients had significantly lower hospital readmission 
rates than other patients. The lower readmission rate for intervention patients alone generated an 
estimated savings of $606,400, for a total cost of $31,500 (benefit cost ratio of 19:1), for an 
average cost of $154 for 205 brief interventions. 
 
Summary: Although the findings support the use of certain SBIRT components on economic 
grounds, the studies should be used cautiously. The cost effectiveness of SBIRT may vary 
considerably, depending on how the technology is applied. If a program is aimed at a selected, 
high-risk portion of the population (e.g., emergency room patients with injury or trauma), a 
higher rate of risky drinkers will be identified than in a “population approach” (e.g., all members 
of an HMO), where a cross-section of the entire population is screened (133). This issue will 
affect the rate at which people receive an SBIRT service and the economic efficiency of any such 
operation. Similarly, the potential for cost savings is much greater among a higher risk portion of 
the population. The labor cost of personnel designated to screen and conduct brief intervention, 
and whether SBIRT is their sole function or is incorporated into other functions will affect cost 
effective calculations. Additionally, the extent of the intervention– whether one five-minute 
session at the time of the screening, or multiple sessions of longer duration on different days–will 
significantly affect both treatment costs and costs incurred by patients. 
 
CONCLUSION: TRANSLATING RESEARCH INTO PRACTICE 
 
In the parlance of contemporary medical science, “translation” has three inter-related meanings: 
(1) applying what we have learned from research to practical settings; (2) making scientific 
knowledge accessible and relevant to practitioners; and (3) improving the health of the 
population by broad dissemination of effective medical and health promotion technologies. 
Translation from research to practice can be considered at two levels: (1) from the laboratory 
“bench” to the patient’s “bedside”; and (2) from bedside to the entire community. In the former 
(called T1 translation), basic science research leads to new clinical investigation and 
interventions. Examples of T1 bench to bedside applications from the 25 years of SBIRT 
research considered in this review include the discovery of biomarkers for alcohol and drug 
screening, the use of psychometric theory to develop new self-report screening tests, and the 
development of new medications to dampen alcohol craving, reduce heavy drinking, and/or 
promote abstinence. Examples of the second form of translation, where clinical investigation 
leads to improved medical practice and enhanced population health (called T2 translation), are 
studies of SBIRT training, program implementation and cost effectiveness. Al- though much 
work needs to be done at both T1 and T2 levels, the findings of this review indicate that 
significant progress has been made in translating research into practice. For example, since 1980: 
  
• Several hundred empirical studies on screening, brief intervention, referral and 
integration of SBIRT into health care settings have been conducted. 
• Over 25 screening tests have been developed and validated. 
• Scores of randomized controlled trials of brief intervention have been conducted in a 
wide range of countries. 
• 15 or more integrative reviews of the SBIRT literature have been published. 
• A growing literature on provider training, SBIRT implementation, and new applications 
is now available. 
 
Based on the results of this review, the following conclusions seem warranted about the various 
components of SBIRT: 
 
• Self-report screening tests are reliable and valid under most clinical conditions, but the 
use of screening tests depends on provider and patient characteristics. 
• Self-report response bias can be predicted, detected and minimized. 
• Brief Interventions (BI) can reduce alcohol use for at least 12 months in non-de- pendent 
heavy drinkers. 
• The approach is acceptable to both genders and to adolescents and adults. 
• Cost-effectiveness has been demonstrated in several countries. 
• Brief interventions are effective with smokers and risky drinkers, and there is some 
evidence that they work well with marijuana users. 
• Brief treatments are effective with per- sons who are dependent on alcohol, marijuana or 
other drugs. 
• SBIRT risk reduction materials exist in diverse formats. 
 
After two decades of clinical research, program development and evaluation studies, SBIRT is 
poised for the next step in dissemination. There is general agreement on the need to “broaden the 
base” of treatment by expanding SBIRT services to less severe cases and populations at risk. In 
order for this to happen, the traditional, acute care model of curative medicine will have to be 
expanded to include a new population-based healthcare management perspective in which 
persons experiencing or at risk of substance use disorders are provided with a range of 
preventive, curative, and rehabilitative services. These services should be designed to fit the 
needs of defined populations, with providers organized into networks that attempt to shift 
utilization to lower cost settings or most appropriate level of care. Implementation models are 
currently inadequate to achieve sufficient population reach unless routine screening, which is the 
linchpin of SBIRT, is organized throughout the health care and social service systems. 
Contractual models for screening, brief intervention, and referral may work better in settings 
where there are limited resources or staff resistance. In all cases, it is important to fit the SBIRT 
program to the population, rather than requiring that patients suit the needs of the providers. It is 
clear from the findings of this review as well as other research (134) that population-wide 
measures to implement the various SBIRT components could have a significant effect on 
reducing the burden of illness associated with substance use disorders. 
 
Nevertheless, there are still gaps in the literature, which suggest the need for further re- search. 
Little research has been devoted to the potential role that SBIRT could play to increase access to 
treatment for people with alcohol and drug dependence. Additional research is needed to 
evaluate screening and brief intervention methods for illicit drug users in general medical 
settings. To the extent that SBIRT programs are part of a broader network of specialized and 
general health care services, research is need to determine how best to implement SBIRT pro- 
grams, how to evaluate their impact on indicators of population health (such as alcohol-related 
morbidity and drunk driving rates), and what are the costs and benefits to society. 
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